Maxigen Biotech (Taiwan) Analysis
| 1783 Stock | TWD 48.65 1.95 4.18% |
Maxigen Biotech is overvalued with Real Value of 39.43 and Hype Value of 48.65. The main objective of Maxigen Biotech stock analysis is to determine its intrinsic value, which is an estimate of what Maxigen Biotech is worth, separate from its market price. There are two main types of Maxigen Biotech's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Maxigen Biotech's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Maxigen Biotech's stock to identify patterns and trends that may indicate its future price movements.
The Maxigen Biotech stock is traded in Taiwan on Taiwan Stock Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Maxigen Biotech is usually not traded on National Day of the Republic of China. Maxigen Stock trading window is adjusted to Asia/Shanghai timezone.
Maxigen |
Maxigen Stock Analysis Notes
About 52.0% of the company shares are owned by insiders or employees . The book value of Maxigen Biotech was presently reported as 14.75. The company last dividend was issued on the 19th of August 2021. Maxigen Biotech had 1000:1050 split on the 7th of September 2023. Maxigen Biotech Inc. engages in the development, manufacture, and marketing of biomedical and cosmeceutical skincare products in Taiwan and internationally. Maxigen Biotech Inc. was founded in 1998 and is based in Taoyuan, Taiwan. MAXIGEN BIOTECH is traded on Taiwan Stock Exchange in Taiwan. For more info on Maxigen Biotech please contact the company at 886 3 328 7222 or go to https://mbi-bio.com.Maxigen Biotech Investment Alerts
| About 52.0% of the company shares are owned by insiders or employees |
Maxigen Biotech Thematic Classifications
In addition to having Maxigen Biotech stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ITInformation technology and IT services |
Maxigen Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.02 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Maxigen Biotech's market, we take the total number of its shares issued and multiply it by Maxigen Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Maxigen Profitablity
Maxigen Biotech's profitability indicators refer to fundamental financial ratios that showcase Maxigen Biotech's ability to generate income relative to its revenue or operating costs. If, let's say, Maxigen Biotech is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Maxigen Biotech's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Maxigen Biotech's profitability requires more research than a typical breakdown of Maxigen Biotech's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.19 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16. Technical Drivers
As of the 12th of December 2024, Maxigen Biotech secures the Mean Deviation of 0.9573, risk adjusted performance of 0.0688, and Downside Deviation of 1.31. Maxigen Biotech technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Maxigen Biotech jensen alpha, maximum drawdown, and the relationship between the information ratio and treynor ratio to decide if Maxigen Biotech is priced some-what accurately, providing market reflects its recent price of 48.65 per share.Maxigen Biotech Price Movement Analysis
The output start index for this execution was fourty-one with a total number of output elements of twenty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Maxigen Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Maxigen Biotech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Maxigen Biotech Outstanding Bonds
Maxigen Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Maxigen Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Maxigen bonds can be classified according to their maturity, which is the date when Maxigen Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Maxigen Biotech Predictive Daily Indicators
Maxigen Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Maxigen Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 48088.79 | |||
| Daily Balance Of Power | 0.8298 | |||
| Rate Of Daily Change | 1.04 | |||
| Day Median Price | 48.33 | |||
| Day Typical Price | 48.43 | |||
| Price Action Indicator | 1.3 | |||
| Period Momentum Indicator | 1.95 |
Maxigen Biotech Forecast Models
Maxigen Biotech's time-series forecasting models are one of many Maxigen Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Maxigen Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Maxigen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Maxigen Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Maxigen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Maxigen Biotech. By using and applying Maxigen Stock analysis, traders can create a robust methodology for identifying Maxigen entry and exit points for their positions.
Maxigen Biotech Inc. engages in the development, manufacture, and marketing of biomedical and cosmeceutical skincare products in Taiwan and internationally. Maxigen Biotech Inc. was founded in 1998 and is based in Taoyuan, Taiwan. MAXIGEN BIOTECH is traded on Taiwan Stock Exchange in Taiwan.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Maxigen Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Additional Tools for Maxigen Stock Analysis
When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.